MedPath

Terlipressin Infusion for Management of Post-CABG Refractory Hypotension: A Comparative Study versus Nor-epinephrine Infusio

Not Applicable
Recruiting
Conditions
Circulatory System
Respiratory
Surgery
refractory hypotension after cardiopulmonary bypass in diabetic patients
Registration Number
PACTR201705002221230
Lead Sponsor
Ahmed Mostafa El-Shaarawy
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria

Diabetic patients
Undergoing elective CABG surgery using CPB
Normal ventricular function
Experience refractory hypotension after CPB

Exclusion Criteria

Emergency cardiopulmonary bypass
Pripheral vascular disease
Hepatic or Kidney dysfunction
preoperative unstable conditions such as severe arrhythmia, heart failure or cardiogenic shock

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
correction of hypotension to achieve SAP>90 mmHg and/or MAP>60 mmHg.
Secondary Outcome Measures
NameTimeMethod
Blood glucose levels;Evaluation ofCardiac ischemia markers (serum CK-MB and cTT)
© Copyright 2025. All Rights Reserved by MedPath